Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer

E. Kievit, H.M. Pinedo, H.M.M. Schlüper, E. Boven

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	419-428
Journal	International Journal of Radiation Oncology Biology Physics
Volume	38
DOIs	https://doi.org/10.1016/S0360-3016(97)82501-1
Publication status	Published - 1997

Access to Document

@article{133ffe954e5041118299a3f652a5f561,

title = "Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer",

author = "E. Kievit and H.M. Pinedo and H.M.M. Schl{\"u}per and E. Boven",

year = "1997",

doi = "10.1016/S0360-3016(97)82501-1",

language = "English",

volume = "38",

pages = "419--428",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer

AU - Kievit, E.

AU - Pinedo, H.M.

AU - Schlüper, H.M.M.

AU - Boven, E.

PY - 1997

Y1 - 1997

U2 - 10.1016/S0360-3016(97)82501-1

DO - 10.1016/S0360-3016(97)82501-1

M3 - Article

VL - 38

SP - 419

EP - 428

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

ER -